Skip to main content
. 2016 Jan 11;50(4):318–321. doi: 10.4132/jptm.2015.10.17

Fig. 3.

Fig. 3.

Photomicrographs of immunohistochemistry (IHC) for c-erbB2 in mixed adenoneuroendocrine carcinoma with trilineage histologic differentiation. IHC for c-erbB2 shows strong positivity in the adenocarcinoma component (A), and in the metastatic regional lymph nodes (B), whereas IHC for c-erbB2 is negative in neuroendocrine carcinoma (C) and squamous cell carcinoma component (D).